274 related articles for article (PubMed ID: 10432161)
1. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
[TBL] [Abstract][Full Text] [Related]
2. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
Reiter PD; Robles J; Dowell EB
Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
[TBL] [Abstract][Full Text] [Related]
3. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters.
Rickard CM; Lipman J; Courtney M; Siversen R; Daley P
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):650-5. PubMed ID: 15357156
[TBL] [Abstract][Full Text] [Related]
4. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
Raad I; Hanna HA; Awad A; Alrahwan A; Bivins C; Khan A; Richardson D; Umphrey JL; Whimbey E; Mansour G
Infect Control Hosp Epidemiol; 2001 Mar; 22(3):136-9. PubMed ID: 11310690
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing for intravascular administration set replacement.
Ullman AJ; Cooke ML; Gillies D; Marsh NM; Daud A; McGrail MR; O'Riordan E; Rickard CM
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD003588. PubMed ID: 24037784
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
Maki DG; Botticelli JT; LeRoy ML; Thielke TS
JAMA; 1987 Oct; 258(13):1777-81. PubMed ID: 3114506
[TBL] [Abstract][Full Text] [Related]
7. Optimal timing for intravenous administration set replacement.
Gillies D; O'Riordan L; Wallen M; Morrison A; Rankin K; Nagy S
Cochrane Database Syst Rev; 2005 Oct; (4):CD003588. PubMed ID: 16235329
[TBL] [Abstract][Full Text] [Related]
8. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units.
Freeman J; Goldmann DA; Smith NE; Sidebottom DG; Epstein MF; Platt R
N Engl J Med; 1990 Aug; 323(5):301-8. PubMed ID: 2082952
[TBL] [Abstract][Full Text] [Related]
9. Timing of intravenous administration set changes: a systematic review.
Gillies D; O'Riordan L; Wallen M; Rankin K; Morrison A; Nagy S
Infect Control Hosp Epidemiol; 2004 Mar; 25(3):240-50. PubMed ID: 15061417
[TBL] [Abstract][Full Text] [Related]
10. Endemic infusate contamination and related bacteremia.
Macias AE; de Leon SP; Huertas M; Maravilla E; Romero C; Montoya TG; Muñoz JM; Lopez-Vidal Y
Am J Infect Control; 2008 Feb; 36(1):48-53. PubMed ID: 18241736
[TBL] [Abstract][Full Text] [Related]
11. In-line filters in central venous catheters in a neonatal intensive care unit.
van den Hoogen A; Krediet TG; Uiterwaal CS; Bolenius JF; Gerards LJ; Fleer A
J Perinat Med; 2006; 34(1):71-4. PubMed ID: 16489888
[TBL] [Abstract][Full Text] [Related]
12. Lipid emulsions and bacteremia in the NICU.
N Engl J Med; 1991 Jan; 324(4):267-8. PubMed ID: 2012639
[No Abstract] [Full Text] [Related]
13. Is bloodstream infection preventable among premature infants? A tale of two cities.
Aly H; Herson V; Duncan A; Herr J; Bender J; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1513-8. PubMed ID: 15930211
[TBL] [Abstract][Full Text] [Related]
14. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants.
Fox M; Molesky M; Van Aerde JE; Muttitt S
Can J Gastroenterol; 1999 Mar; 13(2):147-51. PubMed ID: 10203434
[TBL] [Abstract][Full Text] [Related]
15. Compatibility of drug infusions in the NICU.
Kalikstad B; Skjerdal A; Hansen TW
Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
[TBL] [Abstract][Full Text] [Related]
16. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions.
Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T
Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361
[TBL] [Abstract][Full Text] [Related]
17. Parenteral Nutrition-Associated Cholestasis in Premature Infants: Role of Macronutrients.
Gupta K; Wang H; Amin SB
JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):335-41. PubMed ID: 25316680
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial pediatric bacteremia: the role of intravenous set contamination in developing countries.
Macías AE; Muñoz JM; Herrera LE; Medina H; Hernández I; Alcántar D; Ponce de León S
Infect Control Hosp Epidemiol; 2004 Mar; 25(3):226-30. PubMed ID: 15061415
[TBL] [Abstract][Full Text] [Related]
19. Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.
Auriti C; Ravà L; Di Ciommo V; Ronchetti MP; Orzalesi M
J Hosp Infect; 2005 Apr; 59(4):292-8. PubMed ID: 15749316
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
